The COVID-19 pandemic influenced the year 2020, and Pharma was not only at the vanguard of attempts to combat the virus, but it was also vulnerable to the impacts of lockdowns. The hunt for a vaccine displaced existing capacity and clinical development programs, but it sparked unprecedented industrial collaboration. It also showcased the industry's remarkable adaptability and innovation. Long-term effects of the COVID-19 pandemic on the pharmaceutical sector in both global and local levels could include slowed industry growth, delays in approvals, and self-sufficiency in the pharm-production supply chain, as well as trend changes in health-market product consumption and ethical crises.
Title : Mucoadhesive electrospun fibrous systems for the fast and sustained delivery of drugs
Luis Jesus Villarreal Gomez, Autonomous University of Baja California, Mexico
Title : Pharmaceutics 2023, Singapore, Abstract Pathology and Patient Safety: The Vital Role of Electronic Medical Record and Pathology Informatics in Error Reduction and Precision Medicine
Consolato M Sergi, University of Ottawa, Canada
Title : Values based practice and the impact on Drug discovery, regulation of the Pharma industry and consent in healthcare”
Ashok Handa, Collaborating Centre for Values Based Practice, United Kingdom